For international orders (non-US), use this site. For US orders only, visit ArcherDx has discontinued the SureShot Fusion Controls, catalog nos. AK0035-4 and AK0036-4. We do not currently offer an alternative but are committed to providing customers with high-quality support and service. ArcherDx recommends evaluating alternate solutions from Horizon and SeraCare.

Archer® FusionPlex® Sarcoma Kit

A targeted sequencing assay to simultaneously detect and identify fusions of 26 genes associated with soft tissue cancers. Read More...
Select Product(s)

Archer FusionPlex Sarcoma Kit - 8 reactions


Accessory Products

Archer MBC Adapters A17-A24



Archer MBC Adapters A25-A32



Archer MBC Adapters A33-A40



Archer MBC Adapters A41-A48



Product Highlights

The Archer FusionPlex Sarcoma Kit is a targeted sequencing assay to simultaneously detect and identify fusions of 26 genes associated with soft tissue cancers. Using Archer’s proprietary Anchored Multiplex PCR-based enrichment (AMPTM), fusions of all genes in this kit can be identified in a single sequencing assay, even without prior knowledge of fusion partners or breakpoints.

  • Comprehensive - identify sarcoma-related fusions in a single assay
  • Detailed - characterize fusion partners at single-nucleotide resolution
  • Innovative - first comprehensive NGS-based sarcoma fusion test on the market
  • Streamlined - reduce turn-around time and reduce reflex testing

Frequently Purchased Together


Product Literature

Report on FFPE Extraction Methods

White Paper | PDF2 MB

PreSeq RNA QC Assay

White Paper | PDF< 1 MB

Archer FusionPlex Assay Targets

Brochure | PDF1 MB

Archer FusionPlex NGS Assays

Brochure | PDF2 MB

Archer FusionPlex Sarcoma Panel

Brochure | PDF2 MB

Manuals and Support Information

All Archer FusionPlex Support 

Related Products

MiSeq Reagent Kits v2

MiSeq sequencing reagents in pre-filled, ready-to-use cartridges. Micro and nano formats are available for low output applications.

MiniSeq Reagent Kit

MiniSeq Reagent Kits bring the power of Illumina NGS to labs of all sizes. Access cost-efficient sequencing, even for low numbers of samples.

NextSeq 500/550 v2 and v2.1 Kits

These sequencing reagent kits offer a simplified workflow and improved data quality compared to the prior v1 kit version.

  1. Burningham Z, Hashibe M, Spector L, Schiffman JD. The epidemiology of sarcoma. Clin. Sarcoma Res. Oct 4;2(1), 14 (2012).
  2. Seattle Cancer Care Alliance, Sarcoma Website
  3. Demicco EG, Maki RG, Lev DC, Lazar AJ. New therapeutic targets in soft tissue sarcoma. Adv. Anat. Pathol. May 19(3), 170-80 (2012).
  4. Ducimetiere F, Lurkin A, Ranchere-Vince D, et al. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing. PLoS One (2011).
  5. Coindre JM, Pelmus M, Hostein I, Lussan C, Bui BN, Guillou L. Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases. Cancer Dec 15 98(12) (2003).